Taking the Johnson & Johnson coronavirus vaccine, which has come under scrutiny for possible links to heart and neurological conditions, is worth any potential risks, the Centers for Disease Control and Prevention said.
Dr. Hannah Rosenbaum, a CDC researcher, told the agency’s Advisory Committee on Immunization Practices Thursday that the J&J vaccine is secure despite its small number of drawbacks.
“Many hospitalizations, ICU admissions and deaths can be prevented through Janssen and mRNA COVID-19 vaccines, far outweighing the risks,” she said, CNN reported.
Earlier this month, the Food and Drug Administration added a warning to the J&J vaccine, saying it can lead to an increased risk of a rare neurological condition known as Guillain–Barré syndrome.
Though the FDA said such instances are very rare, about 100 suspected cases reportedly have been identified among the nearly 13 million people who have received the shot.
The FDA also temporarily paused the distribution of the Johnson & Johnson vaccine in early April after concerns of a connection to a rare blood clotting condition, but rescinded the order less than two weeks later.

WI Guest Author

This correspondent is a guest contributor to The Washington Informer.

Leave a comment

Your email address will not be published.